A brief course of anti-TNF-alpha therapy can cure recurrent episodes of HLA-B27-associated severe and refractory heel enthesitis

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1057; author reply 1058.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adalimumab
  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use
  • HLA-B27 Antigen / immunology*
  • Humans
  • Male
  • Rheumatic Diseases / immunology
  • Rheumatic Diseases / therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • HLA-B27 Antigen
  • Tumor Necrosis Factor-alpha
  • Adalimumab